Log In
Print
BCIQ
Print
Print this Print this
 

APD811

  Manage Alerts
Collapse Summary General Information
Company Arena Pharmaceuticals Inc.
DescriptionProstacyclin (IP) receptor (PGI2) agonist
Molecular Target Prostacyclin (IP) receptor (PGI2) (PTGIR)
Mechanism of ActionProstacyclin (IP) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHypertension
Indication DetailsTreat pulmonary arterial hypertension (PAH)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today